Clinical pharmacology of sulfadimethoxine
Kadyków, M.
Polski Tygodnik Lekarski 42(2): 47-50
1987
ISSN/ISBN: 0032-3756 PMID: 3588396 Document Number: 286821
Document emailed within 1 workday
Related Documents
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137Poulsen, H.Enghusen.; Schmitz, O.E.; Brøsen, K. 2002: Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 164(12): 1652
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362
Demchenko, V.T.; Kantariia, V.A.; Kerimov, B.L.; Shogentsukova, E.A.; Shomakhova, N.S. 1984: Clinical pharmacology and clinical pharmacy in a general clinical hospital Sovetskoe Zdravookhranenie 9: 27-29
Moiseev, V.S.; Lepakhin, V.K. 1989: Clinical pharmacology and problems of drug therapy in the clinical picture of internal diseases Terapevticheskii Arkhiv 61(8): 6-10
Simić, D.; Vrhovac, B. 1978: Clinical pharmacology: its importance, place, and role in larger clinical centers Medicinski Pregled 31(9-10): 403-408
Skuratovich, A.A.; Potapnev, F.V.; Borovik, V.Z. 1973: Therapeutic effectiveness of sulfadimethoxine in gonorrhea Vestnik Dermatologii i Venerologii 47(12): 71-74
James, M.O.; Barron, M.G. 1988: Disposition of sulfadimethoxine in the lobster (Homarus americanus) Veterinary and Human Toxicology 30 Suppl. 1: 36-40
Eremeishvili, M.G.; Bobrov, V.I.; Beletskaia, G.T.; Kuzovlev, N.F.; Iakovlev, V.P. 1983: Sulfadimethoxine pharmacokinetics in mechanical jaundice and cholangitis Antibiotiki 28(1): 49-52
Brandão, F.; Polónia, J. 1992: Clinical trials in cardiovascular clinical pharmacology Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 273-281
Bobrov, V.I.; Iushkevich, L.B.; Shashkina, L.F.; Tsarichenko, G.V. 1976: Effect of sulfapyridazine and sulfadimethoxine dust on the blood of workers Gigiena Truda i Professional'nye Zabolevaniya (6): 44-45
Lunde, P.K. 1970: Clinical pharmacology Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(24): 2282-2284
Makarov, V.A.; Koritskii, I.V.; Grudnev, S.A. 1978: The effect of phenobarbital on the acetylation of sulfapyridazine and formation of sulfadimethoxine glucronide in man Farmakologiia i Toksikologiia 41(4): 491-493
Dudley, M.N. 1990: Clinical pharmacology of fluconazole PharmacoTherapy 10(6): 141s-145s
Retterstol, N. 1973: Cannabis--clinical pharmacology Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(28): 2125-2126
Hitzenberger, G. 1990: Clinical pharmacology of ACE inhibitors Wiener Medizinische Wochenschrift 140(1-2): 12-18
Kshirsagar, N. 1991: Clinical pharmacology. Introduction Journal of the Association of Physicians of India 39(12): 941-942
Stochla, K.; Rewerski, W. 1982: Clinical pharmacology of diclofenac Polski Tygodnik Lekarski 37(9-10): 269-272
Ehninger, G.; Proksch, B.; Heinzel, G.; Woodward, D.L. 1986: Clinical pharmacology of mitoxantrone Cancer Treatment Reports 70(12): 1373-1378
Jaillon, P. 2002: The three pillars of clinical pharmacology Therapie 57(1): 3-5